Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USA; The NJH Cohen Family Asthma Institute, National Jewish Health, Denver, CO, USA; Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Denver, CO, USA.
Modena Allergy & Asthma, La Jolla, CA, USA.
Respir Med. 2022 Jun;197:106832. doi: 10.1016/j.rmed.2022.106832. Epub 2022 Apr 7.
SARS-CoV-2 continues to cause a global pandemic and management of COVID-19 in outpatient settings remains challenging.
We sought to describe characteristics of patients with chronic respiratory disease (CRD) experiencing symptoms consistent with COVID-19, who were seen in a novel Acute Respiratory Clinic, prior to widely available testing, emergence of variants, COVID-19 vaccination, and post-vaccination (breakthrough) SARS-CoV-2 infections.
Retrospective electronic medical record data were analyzed from 907 adults with presumed COVID-19 seen between March 16, 2020 and January 7, 2021. Data included demographics, comorbidities, medications, vital signs, laboratory tests, pulmonary function tests, patient disposition, and co-infections. The overdispersed data (aod) R package was used to create a logit model using COVID-19 diagnosis by PCR as the dichotomous outcome variable. Univariate, conventional multivariate and elastic net machine learning were used to analyze data.
Male gender, elevated baseline temperature, and respiratory rate predicted COVID-19 diagnosis. Eosinopenia, neutrophilia, and lymphocytosis were also associated with COVID-19 diagnosis. However, asthma and COPD diagnoses were not associated with SARS-CoV-2 PCR positive test. Male gender, low oxygen saturation, and lower forced expiratory volume in 1 s (FEV) were associated with higher hospital referral.
CRD patients with acute respiratory symptoms in the ambulatory setting were more likely to have COVID-19 if male, febrile and tachypneic. Patients with lower pre-morbid FEV and lower SPO are more likely to be referred to the hospital. A composite of vitals sigs and WBC differential help risk stratify CRD patients seeking care for presumed COVID-19.
SARS-CoV-2 持续引发全球大流行,在门诊环境下管理 COVID-19 仍然具有挑战性。
我们旨在描述在广泛可用的检测、变异出现、COVID-19 疫苗接种和接种后(突破性)SARS-CoV-2 感染之前,在新设立的急性呼吸科诊所就诊、有慢性呼吸道疾病(CRD)且出现符合 COVID-19 症状的患者的特征。
回顾性分析了 2020 年 3 月 16 日至 2021 年 1 月 7 日期间 907 例疑似 COVID-19 成年患者的电子病历数据。数据包括人口统计学特征、合并症、药物、生命体征、实验室检查、肺功能检查、患者处置和合并感染。使用 aod R 包创建了一个使用 PCR 检测的 COVID-19 诊断作为二分类结局变量的逻辑回归模型。使用单变量、传统多变量和弹性网络机器学习分析数据。
男性、基础体温升高和呼吸急促预测 COVID-19 诊断。嗜酸性粒细胞减少、中性粒细胞增多和淋巴细胞增多也与 COVID-19 诊断相关。然而,哮喘和 COPD 诊断与 SARS-CoV-2 PCR 阳性检测结果无关。男性、低血氧饱和度和较低的 1 秒用力呼气量(FEV)与更高的住院转诊相关。
在门诊环境中出现急性呼吸道症状的 CRD 患者,如果为男性、发热和呼吸急促,则更有可能患有 COVID-19。预发病 FEV 较低和 SPO 较低的患者更有可能被转诊到医院。生命体征和白细胞分类的综合指标有助于对因疑似 COVID-19 就诊的 CRD 患者进行风险分层。